330 related articles for article (PubMed ID: 30897972)
1. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
4. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
5. Soy and breast cancer: focus on angiogenesis.
Varinska L; Gal P; Mojzisova G; Mirossay L; Mojzis J
Int J Mol Sci; 2015 May; 16(5):11728-49. PubMed ID: 26006245
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones and cancer prevention.
Sarkar FH; Li Y
Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
[TBL] [Abstract][Full Text] [Related]
7. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
Hillman GG
Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
[TBL] [Abstract][Full Text] [Related]
11. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone.
Li HQ; Luo Y; Qiao CH
Mini Rev Med Chem; 2012 Apr; 12(4):350-62. PubMed ID: 22303948
[TBL] [Abstract][Full Text] [Related]
13. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
14. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Takimoto CH; Glover K; Huang X; Hayes SA; Gallot L; Quinn M; Jovanovic BD; Shapiro A; Hernandez L; Goetz A; Llorens V; Lieberman R; Crowell JA; Poisson BA; Bergan RC
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1213-21. PubMed ID: 14652284
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
16. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
17. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
18. Soy Isoflavones and their Effects on Xenobiotic Metabolism.
Zhou T; Meng C; He P
Curr Drug Metab; 2019; 20(1):46-53. PubMed ID: 29708073
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes.
Davis JN; Kucuk O; Djuric Z; Sarkar FH
Free Radic Biol Med; 2001 Jun; 30(11):1293-302. PubMed ID: 11368927
[TBL] [Abstract][Full Text] [Related]
20. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways.
Li Y; Kong D; Bao B; Ahmad A; Sarkar FH
Nutrients; 2011 Oct; 3(10):877-96. PubMed ID: 22200028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]